These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 22592047)
1. Role of positron emission tomography-computed tomography in the management of anal cancer. Mistrangelo M; Pelosi E; Bellò M; Ricardi U; Milanesi E; Cassoni P; Baccega M; Filippini C; Racca P; Lesca A; Munoz FH; Fora G; Skanjeti A; Cravero F; Morino M Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):66-72. PubMed ID: 22592047 [TBL] [Abstract][Full Text] [Related]
2. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer. Mistrangelo M; Pelosi E; Bellò M; Castellano I; Cassoni P; Ricardi U; Munoz F; Racca P; Contu V; Beltramo G; Morino M; Mussa A Int J Radiat Oncol Biol Phys; 2010 May; 77(1):73-8. PubMed ID: 19632066 [TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer. Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181 [TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography/computed tomography in the staging and treatment of anal cancer. Sveistrup J; Loft A; Berthelsen AK; Henriksen BM; Nielsen MB; Engelholm SA Int J Radiat Oncol Biol Phys; 2012 May; 83(1):134-41. PubMed ID: 22000745 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer. De Nardi P; Guarneri G; Canevari C; Tamburini A; Slim N; Passoni P; Rosati R Colorectal Dis; 2019 Sep; 21(9):1017-1024. PubMed ID: 31077550 [TBL] [Abstract][Full Text] [Related]
6. FDG-PET/CT in the evaluation of anal carcinoma. Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889 [TBL] [Abstract][Full Text] [Related]
7. DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark. Jakobsen JK; Alslev L; Ipsen P; Costa JC; Krarup KP; Sommer P; Nerstrøm H; Toft BG; Høyer S; Bouchelouche K; Jensen JB BJU Int; 2016 Jul; 118(1):102-11. PubMed ID: 26216234 [TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy in squamous-cell carcinoma of the anal canal. De Nardi P; Carvello M; Canevari C; Passoni P; Staudacher C Ann Surg Oncol; 2011 Feb; 18(2):365-70. PubMed ID: 20803079 [TBL] [Abstract][Full Text] [Related]
9. Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes. Rosevear HM; Williams H; Collins M; Lightfoot AJ; Coleman T; Brown JA Urol Oncol; 2012 Sep; 30(5):723-6. PubMed ID: 21396850 [TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation. Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Ono CR; Lynn P; Bailão Aguilar P; Nahas SC; Gama-Rodrigues J; Buchpiguel CA Colorectal Dis; 2013 Jun; 15(6):674-82. PubMed ID: 23374979 [TBL] [Abstract][Full Text] [Related]
11. The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis. Jones M; Hruby G; Solomon M; Rutherford N; Martin J Ann Surg Oncol; 2015 Oct; 22(11):3574-81. PubMed ID: 25652048 [TBL] [Abstract][Full Text] [Related]
12. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma. Blom RL; Vliegen RF; Schreurs WM; Belgers HJ; Stohr I; Oostenbrug LE; Sosef MN Dis Esophagus; 2012 Aug; 25(6):555-9. PubMed ID: 22150869 [TBL] [Abstract][Full Text] [Related]
13. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy. Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091 [TBL] [Abstract][Full Text] [Related]
14. Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival. Mohammadkhani Shali S; Schmitt V; Behrendt FF; Winz OH; Heinzel A; Mottaghy FM; Eble MJ; Verburg FA Eur J Radiol; 2016 Aug; 85(8):1390-4. PubMed ID: 27423677 [TBL] [Abstract][Full Text] [Related]
16. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837 [TBL] [Abstract][Full Text] [Related]
18. PET/CT in anal cancer - is it worth doing? Wells IT; Fox BM Clin Radiol; 2012 Jun; 67(6):535-40. PubMed ID: 22208962 [TBL] [Abstract][Full Text] [Related]
19. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers. Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604 [TBL] [Abstract][Full Text] [Related]
20. Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients. Slim N; Passoni P; Incerti E; Tummineri R; Gumina C; Cattaneo GM; De Nardi P; Canevari C; Fiorino C; Ronzoni M; Tamburini AM; Burgio V; Gianolli L; Di Muzio N Sci Rep; 2020 Sep; 10(1):14613. PubMed ID: 32884036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]